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Objectives: In patients after the Fontan operation, we determined risk factors for late
failure and for intra-atrial re-entrant tachycardia at 15 to 20 years’ follow-up.
Midterm results after electrophysiologic ablation therapy for these tachycardias
were also evaluated.
Methods: Current follow-up was available in 162 patients (2005 patient-years) with
a wide range of underlying diagnoses operated on between February 1978 and May
1995. Risk factor analysis included patient-related and procedure-related variables,
with late failure and the incidence of re-entrant tachycardia as outcome parameters.
Results: Forty late failures were observed (2.0 per 100 patient-years). At 15 years,
Kaplan-Meier estimated survival was significantly (P  .007) better for patients
with tricuspid atresia (93%) compared with that for patients with complex congenital
malformation (71%). The sole multivariable risk factor for Fontan failure was the type
of underlying diagnosis. At 20 years’ follow-up, overall freedom from tachycardia was
estimated to be 46%  12%. Acute success of electrophysiologic ablation was seen in
25 (83%) of 30 patients, and Kaplan-Meier estimated freedom from recurrent tachy-
cardia was 81%  10% at 3 years. Multivariate analysis identified duration of Fontan
circulation as the sole risk factor for re-entrant tachycardias.
Conclusion: After the modified Fontan operation, long-term survival in patients with
tricuspid atresia was significantly better compared with that in patients with com-
plex congenital malformations. As first-choice therapy for atrial re-entrant tachy-
cardias, we recommend electrophysiologic ablation therapy.
The development of intra-atrial re-entrant tachycardia (IART) exposespatients after long-term Fontan circulation to serious morbidity.1-4Depending of the Fontan population and the time of follow-up,Kaplan-Meier estimates of freedom from tachycardias vary in a widerange from 12.5% to 80%.1,2,5-8 Antiarrhythmic drug therapy, anti-tachycardia pacing, or both offer limited arrhythmia control. A few
small series report the use of electrophysiologic mapping and radiofrequency
ablation techniques with good acute success rates but high early recurrence rates of
arrhythmia.9,10 Therefore in patients with tachycardia undergoing the Fontan oper-
ation, conversion to a total cavopulmonary connection combined with a modified
Cox maze procedure has been advocated.11-13 Recent data from patients with a total
cavopulmonary connection showed that we can expect significantly fewer patients
with tachycardia after this technique as opposed to patients after the classical Fontan
operation and its modification.14
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The purpose of this article is to document our results
with radiofrequency ablation therapy of tachycardia in pa-
tients after the Fontan operation. We determined patient-
and procedure-related risk factors influencing late Fontan
failure, development of IARTs, and management strategy.
Methods
Patient Population
Patients undergoing modifications of the Fontan procedure at the
German Heart Centre Munich operated on between February 1978
and May 1995 were studied. The indication for the modified
Fontan operation was given when a significant increase of cyano-
sis, reduction of physical capabilities, or both was observed. In
each patient preinterventional and postinterventional data were
extracted by means of review of the medical records or personal
contact. Preoperative cardiac catheterization data were available
for all patients and, in conjunction with echocardiographic data,
served as the basis for assessment of atrial and ventricular mor-
phology and hemodynamic data. The actual clinical condition was
verified in the outpatient pediatric cardiology department. To fa-
cilitate data analysis on the basis of the morphology of the under-
lying congenital heart disease, we assigned the patients either to a
tricuspid atresia (TrA) group or to a complex congenital malfor-
mation (CCM) group, who were not amenable for 2-ventricle
repair. Patients with a hypoplastic left heart syndrome were not
referred for surgical therapy at that time. Also, patients were
assigned to the type of Fontan pathway: either right atrial to right
ventricle (RA-RV) or right atrial to pulmonary artery (RA-PA)
types of Fontan procedures. During that time, the RA-PA connec-
tion was either a direct RA-PA anastomosis, or the connection was
performed with allografts or with a lateral tunnel of autologous
atrial tissue. Prosthetic material, as used in recent modifications for
total cavopulmonary connections, was not used.
Electrophysiologic Technique
If patients had been treated unsuccessfully with an average of 3
antiarrhythmic drugs, an ablation procedure was indicated. Anti-
arrhythmic drugs were discontinued more than 5 plasma half-lives
before the study. For the procedure, patients were sedated with
midazolam (1-2 mg administered intravenously). A 64-electrode
basket catheter (Constellation; EP Technologies, San Jose, Calif),
providing 56 bipolar electrocardiograms, was placed in the right
atrium through an 11F-long sheath inserted from the femoral or
internal jugular veins. On the basis of echocardiographic estima-
tion of right atrial dimensions, basket diameters between 48 and 90
mm were used.15,16 After basket catheter deployment, a 5F deca-
polar catheter with an interelectrode distance of 2 to 10 mm
spacing between electrodes was positioned in the coronary sinus
(in cases when the coronary sinus was not surgically drained in the
left atrium) to detect small changes in intracardiac position. The
third catheter was used as a roving catheter to record and pace
from selected sites in the right atrium and to perform radiofre-
quency ablation.
Definitions
Fontan survivors were defined as patients with an intact Fontan
pathway of any modification. Fontan failure was defined as death
at the time of last follow-up because during late follow-up, no
takedown of the Fontan circulation to a systemic to pulmonary
shunt procedure was performed. Time to IART was defined as the
period beginning 30 days after the Fontan procedure and extending
to the date of the first electrophysiologic investigation. By defining
time to IART in this way, the uncertain effects of early arrhythmias
in patients without frequent follow-up were eliminated. Patients
with antiarrhythmic drugs and regular sinus rhythm were censored
at the time of the most recent follow-up.
Statistical Analysis
Overall late Fontan failure and the incidence of postoperative
IARTs served as outcome parameters. The influence of early
mortality was eliminated by defining survival time as the period
beginning 30 days after the Fontan procedure. Patients in whom
the Fontan circulation did not fail were censored at the time of last
follow-up. Estimated actuarial survival and freedom from IARTs
were determined by using the Kaplan-Meier method. Significance
during univariable analysis was assessed by using the log-rank test
when the type of diagnosis for Fontan survival and the type of
Fontan anastomosis for IART were the outcome parameters during
the Kaplan-Meier procedure. For multivariable analysis, the Cox
proportional-hazards regression model was used to establish the
variables independently predictive of Fontan failure and the inci-
dence of IARTs. Hazard ratios with 95% confidence intervals were
constructed for the significant multivariable predictors. Final mod-
els were derived by using the forward stepwise selection proce-
dure. Variables having P value of less than .1 in the univariable
analyses were entered as candidates into the Cox regression mod-
els. A P value of less than .05 was required for the variable to be
retained in the equation. All reported P values are 2 tailed. Statis-
tical analysis was performed with the SPSS software package
(version 10.1; SPSS, Inc, Chicago, Ill). Data are presented as
means  SEM or SD as indicated.
Results
Patient Characteristics
A total of 182 modified Fontan procedures have been per-
formed during the study period, and 162 long-term survi-
vors (2005 patient-years) were included in the study.
Eighty-four patients were male, and 78 were female. In 92
patients the diagnosis of TrA was the leading cardiac mal-
formation. Seventy patients with a wide range of underlying
cardiac malformations were summarized as having CCMs.
Forty-five patients had no palliative procedures before the
Fontan operation. One hundred seventeen patients had pre-
viously undergone a total of 160 palliative procedures: 63
patients had at least one systemic to pulmonary artery shunt,
43 patients had pulmonary artery banding, 5 patients had
coarctation repair, 1 patient had a bidirectional Glenn pro-
cedure, and 5 patients had comissurotomy of the pulmonary
valve. Age at first palliation was not significantly (P .255)
different for patients with TrA and CCMs, being 2.4  3.5
years (median, 0.75 years) and 1.8  2.4 years (median, 0.8
years), respectively. From the total of 162 patients, 40 late
Fontan failures occurred (1.99 per 100 patient-years).
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For RA-RV anastomoses, either the Bjoerk17 modifica-
tion (n  60) with a polytetrafluoroethylene* tunnel or an
allograft (n  10) was used. For RA-PA connection, either
a direct right atrial to pulmonary artery anastomosis (n 
26)18 or allografts (n  14) or a lateral tunnel constructed
with autologous atrial tissue (n  52) was used. Between
patients with Fontan failure and survivors, no significant
difference for preoperative mean pulmonary artery pressure,
mean indexed pulmonary artery resistance, mean right atrial
pressure, mean ventricular end-diastolic pressure, and mean
hematocrit and hemoglobin values was found (Table 1).
Preoperatively, 154 (95.1%) patients were in sinus rhythm,
and 4 patients showed atrial fibrillation or intermittent
tachycardias that could be controlled by medical therapy. In
2 patients pacemakers for treatment of bradyarrhythmia
were implanted. The mean age at the time of the Fontan
operation was significantly (P  .04) different, being 7.8 
5.9 (SD) years (median, 6.1 years) for patients with TrA and
9.7 5.6 years (median, 7.8 years) for patients with CCMs.
The mean Fontan circulation time was significantly (P 
.002) longer for patients with TrA (13.5  4.8 years;
median, 13.9 years) compared with that for patients with
CCMs (10.9  5.3 years; median, 12.4 years). The Kaplan-
Meier estimate of overall freedom from Fontan failure was
89.0%  2.4%, 83.0%  3.8%, 77.0%  3.5%, and 59.0%
 7.7% at 5, 10, 15, and 20 years’ follow-up (Figure 1). The
Kaplan-Meier estimate of freedom from Fontan failure at 15
years was significantly (P  .007, log-rank test) higher for
patients with TrA (83.0%  4.0%) compared with that for
patients with CCMs (70.8%  5.5%). In 17 (11%) patients
conversion of the modified Fontan pathway to total cavo-
pulmonary connection was performed during follow-up.
Surgical Procedures
The mean duration of cardiopulmonary bypass time was
significantly (P  .001) shorter for patients with TrA (90.0
 22.0 minutes; range, 30-153 minutes) compared with that
for patients with CCMs (122.0  37.0 minutes; range,
52-210 minutes). In addition, the crossclamp time was sig-
nificantly (P  .005) shorter in patients with TrA (50.0 
17.0 minutes; range, 4-79 minutes) than in patients with
CCMs (62.0  29.0 minutes; range, 2-132 minutes). How-
*Gore-Tex, registered trademark of W. L. Gore & Associates, Inc, Newark,
Del.
Figure 2. Kaplan-Meier estimates of the probability of freedom
from atrial flutter. Time zero is 30 days after the Fontan operation.
Numbers of patients at risk are shown in parentheses.
TABLE 1. Preoperative cardiac catheterization data (mean
 SD) in patients undergoing the modified Fontan opera-
tion
Late Fontan failure
No
(n  122)
Yes
(n  40)
P
value
Right atrial pressure
(mm Hg)
6.0 3.0 6.0 2.4 .88
Left atrial pressure
(mm Hg)
5.5 2.9 5.9 3.0 .50
Pulmonary artery
pressure (mm Hg)
12.5 5.1 12.9 3.5 .70
Ventricular end-diastolic
pressure (mm Hg)
6.7 2.8 6.7 3.2 .93
Pulmonary resistance
(dyn  s5  cm5)
1.4 0.8 1.7 .9 .14
Hemoglobin (g/dL) 19.1 2.5 18.7 2.9 .42
Hematocrit (%) 57.5 8.4 55.5 7.7 .22
Figure 1. Kaplan-Meier estimates of the probability of late sur-
vival with a Fontan circulation. Time zero is 30 days after the
Fontan operation. Numbers of patients at risk are shown in
parentheses.
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ever, univariable and multivariable analysis identified the
type of diagnosis (TrA vs CCM) as the only variable sig-
nificantly associated with late Fontan failure (Table 2).
Patients With IART
A total of 30 (18.5%) long-term Fontan survivors had a
history of intermittent or chronic IART (Figure 2), which
was treated through the electrophysiologic approach. The
Fontan circulation time was significantly (P  .003, log-
rank test) longer in patients who underwent electrophysi-
ologic testing (14.9  3.1 years; median, 14.5 years) com-
pared with in patients without testing (11.8  5.4 years;
median, 12.7 years). Univariable testing exhibited that the
prevalence of atrial flutter was significantly (P  .05, log-
rank test) different for the 2 types of Fontan pathways: 18
(20%) of 92 patients with the RA-PA Fontan modification
experienced IARTs versus 12 (17%) of 70 patients with
RA-RV connections (Figure 3). Yet multivariable Cox re-
gression analysis failed to associate the type of Fontan
pathway as an independent risk factor for the development
of IART (Table 2). The variable of reoperation (among
them 17 patients with conversion of the Fontan pathway to
total cavopulmonary connection) did not reach significance
either for late failure or for incidence of tachycardia. In 3
patients, before electrophysiologic ablation therapy, conver-
sion with intracardiac baffling was performed. At that time,
patients did not have re-entrant tachycardia but rather had
other signs of Fontan disease. In one patient targeted exci-
sion of a left atrial tachycardia triggering focus in combi-
nation with conversion to cavopulmonary connection was
performed. At follow-up, this patient presented with sinus
rhythm. The age at the time of the Fontan operation in
patients in whom tachycardias developed (8.1  5.5 years;
median, 6.5 years) was not significantly different than that
of those without tachycardias (8.7  5.9 years; median, 6.8
years).
During the first electrophysiologic approach, ablation of
the tachycardia was not possible in 5 (17%) patients (Table
3). The mean number of radiofrequency applications was 29
 15 (range, 14-59). Fluoroscopic time was 39  13
minutes (range, 20-65 minutes). In patients with initially
successful ablation procedures, a total of 46 different sus-
tained atrial tachycardias were induced (a mean of 1.8
tachycardias per patient). The critical isthmus was localized
at 2 major sites: (1) the region between the tricuspid annulus
and the inferior vena cava (22 patients) and (2) the area
TABLE 2. Predictors of late failure and IART after the
modified Fontan operation
Variable
Univariable Multivariable
P value Risk ratio* 95% CI P value
Late failure
Age .20
Diagnosis .007 2.3 1.2-4.5 .009
SV-morphology .06
Heterotaxy syndrome .87
Pulmonary artery band .54
Surgical modification .33
Reoperation .10
Primary Fontan .20
Allograft .42
IART
Age .27
Diagnosis .30
SV-morphology .97
Pulmonary artery band .59
Surgical modification .05
Reoperation .21
Primary Fontan .46
Allograft .77
Follow-up .001 .008 .00-.26 .006
Fontan failure .17
CI, Confidence interval; Age, age at Fontan operation (4 years); Diagno-
sis, tricuspid atresia versus complex congenital malformation; SV-morphol-
ogy, left or right single-ventricle morphology; Pulmonary artery band,
pulmonary artery banding versus systemic to pulmonary artery shunt;
Surgical modification, right atrial to pulmonary versus right atrial to right
ventricle connection; Primary Fontan, without pre-Fontan palliation; Allo-
graft, right atrium to pulmonary artery or right ventricle connection with an
allograft; Follow-up, Fontan circulation time less than 15 years.
*Risk ratio represents the hazards ratio from the Cox proportional-hazards
model.
Figure 3. Kaplan-Meier estimates of the probability of freedom
from atrial flutter as a function of the type of Fontan operation:
RA-PA, right atrial to pulmonary artery (solid line); RA-RV, right
atrial to right ventricle (dashed line). Time zero is 30 days after
the Fontan operation. Numbers of patients at risk are shown in
parentheses. The type of Fontan operation was significantly (P 
.05, log-rank test) different for patients in whom atrial flutter
developed.
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between the inferior border of a lateral atriotomy and the
inferior vena cava (9 patients). Also, the area between the
superior border to the superior vena cava and the area
between the septal patch to the inferior vena cava was
frequently involved. In 3 patients tachycardia manifested as
focal tachycardia. Two patients underwent repeat electro-
physiologic testing, and tachycardias could finally be ab-
lated. The other patients are awaiting surgical therapy. The
mean follow-up duration in patients with successful ablation
was 1.7 years (95% confidence interval, 1.2-2.3 years). The
Kaplan-Meier estimates for freedom from tachycardia in
patients with initially successful ablation was 81%  10%
at 3 years’ follow-up (Figure 4).
Discussion
The present study demonstrates that in patients with modi-
fied Fontan procedures, the incidence of IART significantly
contributes to late morbidity. At 20 years, Kaplan-Meier
analysis estimated 46% of the patients to be free from
IART. Multivariable Cox regression testing revealed the
duration of Fontan circulation as the sole risk factor asso-
ciated with IART. By using recently introduced electro-
physiologic techniques for electroanatomic atrial mapping,
identification of the pathologic pathways and ablation
therapy can achieve sinus rhythm in a high percentage of
the patients. Surgical intervention should therefore be re-
served for those patients with failed electrophysiologic ther-
apy.
Risk Factors for Late Fontan Failure
The surgical procedures used in this Fontan series resulted
in a functional status that was found to be comparable with
data reported in the literature.19 Four large series1,2,8,20 have
provided important information about late outcome after the
modified Fontan operation. Yet comparison of outcome
measures between institutions is not possible without fully
TABLE 3. Patient characteristics
IDNR Diagnosis Age at Fontan (y)
Fontan circulation
(y) Fontan operation
EPM
follow-up
(y)
Follow-up
Rhythm Treatment
337 TrA 0.5 13.6 RA-RV conduit 0.5 SR -blocker
167 TrA 10.7 14.3 RA-RV conduit 0.2 SR Amiodarone
153 TrA 2.5 11.6 RA-RV conduit 2.4 SR Amiodarone
149 TrA 4.8 14.0 RA-RV conduit 5.0 SR -blocker
134 TrA 5.8 12.2 RA-RV conduit 3.6 SR
112 TrA 1.4 14.1 RA-RV conduit 0.7 SR -blocker
106 TrA 2.1 15.8 RA-RV conduit 2.7 SR -blocker
104 TrA 15.9 17.7 RA-RV conduit 1.1 SR Amiodarone
103 TrA 2.9 18.8 RA-RV conduit 0.9 SR
094 TrA 7.3 20.7 RA-RV conduit 0.9 SR -blocker
092 TrA 1.4 19.1 RA-RV conduit 0.5 SR Amiodarone
076 TrA 3.5 18.3 RA-RV conduit 4.3 IART Propafenone
087 TrA 4.7 19.9 RA-PA allograft 2.7 SR Amiodarone
228 TrA 15.3 14.8 RA-PA allograft 0.9 IART -blocker
068 TrA 7.5 16.7 RA-PA allograft 3.4 IART -blocker
064 TrA 10.7 15.9 RA-PA allograft 2.4 PM -blocker
070 TrA 6.1 16.6 RA-PA direct 1.2 SR
151 CCM 7.6 7.2 RA-PA direct 1.0 IART
119 CCM 18.0 13.6 RA-PA direct 2.8 IART Amiodarone
038 CCM 8.0 18.1 RA-PA conduit 0.6 SR Targeted excision
176 CCM 13.0 9.7 Lateral tunnel 3.0 SR -blocker
057 TrA 6.0 15.1 Lateral tunnel 0.4 SR -blocker
169 CCM 6.9 11.2 Lateral tunnel 1.3 SR -blocker
135 CCM 4.5 12.2 Lateral tunnel 1.4 SR
123 CCM 14.5 13.2 Lateral tunnel 2.8 SR -blocker
121 CCM 6.1 12.9 Lateral tunnel 1.0 SR -blocker
033 CCM 16.8 17.2 Lateral tunnel 3.5 IART -blocker
025 CCM 16.2 14.3 Lateral tunnel 1.0 SR
021 CCM 1.8 15.1 Lateral tunnel 0.3 PM -blocker
019 CCM 19.2 14.1 Lateral tunnel 2.3 PM
IDNR, Identification number; TrA, tricuspid atresia; CCM, complex congenital malformation; RA-RV conduit, right atrial to right ventricular connection with
Dacron roof (Fontan-Bjoerk); RA-PA allograft, right atrial to pulmonary artery connection with allograft; RA-PA direct, right atrial to pulmonary artery
connection without foreign material; RA-PA conduit, right atrial to pulmonary artery connection with dacron tube; lateral tunnel, lateral tunnel from right
atrial to pulmonary artery with atrial tissue; EPM, electrophysiologic mapping; SR, sinus rhythm; IART, intra-atrial re-entry tachycardia, PM, pacemaker.
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accounting for patient selection, surgical modifications,
time of operation, interventional catheter techniques, and
postoperative management. Nevertheless, Kaplan-Meier es-
timates of late Fontan failure in our series (eg, at 15 years
being 77.0%  3.5%) are comparable with those published
in the above-mentioned series. Multivariate Cox propor-
tional hazard testing showed the diagnosis of CCM as
significantly associated with Fontan failure. These data in-
dicate that patient-related but not procedure-related vari-
ables determine the outcome in patients undergoing the
Fontan operation during late follow-up.
Risk Factors for IART
The development of tachycardia during the life of a patient
who has undergone the Fontan operation has been a matter
of concern since the introduction of the Fontan procedure in
1971.21 In our Fontan population the development of tachy-
cardia was clearly a time-dependent process (Figure 2). To
overcome the uncertainty of the clinical significance of
IART after the Fontan operation, we defined the time until
the first IART treatment, determined by means of radiofre-
quency ablation, as an outcome parameter. The Kaplan-
Meier estimated freedom from tachycardia is similar to
values published from other series.5,6 In general, patients
with an RA-RV anastomosis had a more simple underlying
cardiac malformation compared with the patients with
RA-PA anastomoses (Figure 3). This might explain why
patients with RA-RV connections had a significantly (dur-
ing univariable analysis) lesser incidence of tachycardia.
Yet in the multivariable Cox proportional-hazard model,
this difference was lost, and duration of follow-up remained
the only significant variable for the development of tachy-
cardia (Table 2). Summarizing the data from this and 2
recent studies5,6 doing an overview of 995 patients under-
going the Fontan operation, the duration of the follow-up
interval,5 prior palliation with atrial septectomy,5 and atrio-
ventricular valve replacement6 remain independent risk fac-
tors for the development of atrial tachycardia after the
modified Fontan operation.
Management for IART
In patients undergoing the Fontan operation, the critical
isthmus for the re-entrant circuit in atrial flutter was located
between the tricuspid annulus, the coronary sinus, and the
Eustachian ridge adjacent to the inferior vena cava.22 This
region was also involved in the majority of our patients. In
addition, further zones of slow conduction that define a
critical isthmus in which radiofrequency ablation is likely to
be successful have been identified and were also targeted:
between the atriotomy and (1) the tricuspid annulus or the
(2) superior or (3) inferior vena cava or (4) between the
tricuspid annulus and the Fontan conduit. We performed an
electroanatomic mapping technique for identification of the
critical tachycardia zone, of which a detailed description has
been recently published.23 This technique offers at least 3
advantages for mapping and guiding ablation of IARTs after
the Fontan operation: (1) acquisition of multiple and simul-
taneous recordings; (2) software-assisted activation maps
that rapidly identify zones of split potentials and slow
conduction that can be further analyzed with an entrainment
technique as possible targets for radiofrequency ablation;
and (3) multiple and stable rows of electrodes representing
a reliable tool to verify the completeness of the ablation
lines.
Early and high recurrence rates of tachycardia after elec-
trophysiologic ablation therapy have been reported in a
small series of patients undergoing the Fontan operation.10
Therefore right atrial Cox maze procedure, pacemaker in-
sertion, and conversion to total cavopulmonary connection
was recommended as first-choice therapy in these pa-
tients.11-13 However, comparison of outcome measures be-
tween institutions is not possible for the same reasons
mentioned above. Furthermore, innovation of the electro-
physiologic technique (eg, introduction of bidirectional pac-
ing to assess lesion continuity and better software) and
gaining experience might influence early and late suc-
cess.16,23 By using this technique, 80% freedom from IART
at 3 years’ follow-up or reduction of tachycardia frequency
could be achieved. In our experience patients with tachy-
cardia do not frequently have a failing Fontan circulation,
which would facilitate indication for conversion to cavopul-
monary connection. Therefore our concept is that surgical
intervention should be reserved for those patients with
Figure 4. Kaplan-Meier estimates of the probability of freedom
from atrial flutter as a function of time after the electrophysi-
ologic ablation procedure in patients with immediate successful
termination of the re-entrant tachycardia. Time zero indicates
after the intervention. Numbers of patients at risk are shown in
parentheses.
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failed electrophysiologic ablation or IARTs with failing
Fontan circulation.
Limitations of the Study
The validity of our study is clearly limited by its retrospec-
tive nature and evaluation of data in a nonconsecutive
patient group. Although long-term follow-up information
was available in a high percentage of the patients, the
incidence of IART is most likely underestimated because of
the transient nature of some arrhythmias and the limited
availability of serial electrocardiographic and Holter stud-
ies. Interpretation of the results is also difficult because
there is a lack of an unoperated or conventionally palliated
patient population as a control group.
Since 1995, we have changed our institutional policy and
abandoned the modified Fontan operations described in this
series. Recent data from patients with total cavopulmonary
anastomoses14 indicate that the lateral tunnel approach with
prosthetic material and early correction of cyanosis consid-
erably reduces the incidence of atrial arrhythmia compared
with that of the patient group presented in this article. Thus
this article might serve as a basis for future studies, clari-
fying the long-term outcome and treatment approach for
IART in patients with the older Fontan modifications.
Conclusions
In this retrospective study we have shown that late survival
after the Fontan operation was significantly determined by
the patients’ underlying congenital malformations. The
long-term survival was estimated to be higher in patients
with TrA compared with that in patients with CCM. IART
develops over time after the Fontan operation, regardless of
the type of underlying morphology. By using 3-dimensional
atrial electroanatomic activation mapping, rapid and com-
prehensive therapy of re-entrant atrial tachyarrhythmias in
patients undergoing the Fontan operation is achieved. Sur-
gical intervention should be reserved for those patients who
do not respond to interventional therapy.
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Discussion
Dr Constantine Mavroudis (Chicago, Ill). Dr Weipert and
associates have presented their experience with 162 patients un-
dergoing the Fontan operation with varying types of venoatrial
pulmonary artery connections. Congratulations on a very nice
presentation. It was clear, succinct, and easy to follow.
Dr Weipert and associates divided their patients into 2 groups,
namely the TrA group and the complex group. The incidence of
atrial tachycardia over time was documented, and they also
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showed the benefits of transcatheter ablation in controlling atrial
arrhythmias in some 25 patients. Their results are better than most
in the literature, but nevertheless, they have a 50% recurrence rate
over a 5-year period. This article was nicely presented and serves
as an important benchmark because of the significant follow-up,
which includes approximately 2000 patient-years.
Our experience at Children’s Memorial Hospital in Chicago
has centered on those patients who had Fontan failure on the basis
of atrial arrhythmias, pathway obstructions, and valvular dysfunc-
tion. In your article you thought that it was unlikely that arrhyth-
mias would be the sole cause of Fontan failure. We have a differing
opinion in that we have seen a number of patients who have had atrial
arrhythmias over long periods of time who have ventricular dysfunc-
tion and have regained their ventricular function after the maze
procedure. Perhaps you could comment on this issue.
I have several other questions. I see from the article that you
excluded patients with hypoplastic left heart syndrome. Is it be-
cause you had few patients like this, or have you excluded others
with other more complex anatomy, and if you did, can you tell us
why?
Also, did you see a difference in the transcatheter ablation
success rate between the patients with TrA and your complex
congenital patients? The reason I ask this is because the patients
with TrA tend to have thicker atrial walls and might not be
treatable by means of energy-giving techniques because of the
difficulty in creating transmural lesions. You might want to give us
some thoughts on that.
And another thing, I did not see in your long follow-up any
patients who had atrial fibrillation. Did any of your patients have
atrial fibrillation? We contend that atrial fibrillation is the natural
course after atrial re-entrant tachycardia for a significant number of
these patients; that is to say, the first arrhythmia is atrial re-entrant
tachycardia followed in time with atrial fibrillation. If you did have
patients like that, did you take these patients to the catheterization
laboratory and try to perform a left- and right-sided maze proce-
dure to convert them or did you operate on them?
We do not have a problem with performing transcatheter ab-
lation for our sets of patients. However, we find that a number of
these patients have pathway obstructions and anatomic problems
as well, and therefore we usually go to surgical intervention with
these patients.
I look forward to your comments, and I also look forward to
your transcatheter techniques getting better, where these patients
hopefully will not have to have an operation that is as large as this
one.
Dr Weipert. Thank you very much, Dr Mavroudis. I skipped
the problem of conversion operation to total cavopulmonary con-
nection in these patients, but we did 17 conversions in patients
with the full symptoms of Fontan disease, such as together with
fibrillation, flutter, and protein-losing enteropathy, and there was a
mortality rate of about 25%. Therefore we are reluctant to go ahead
and do the operation in patients who have flutter, which I could
present here.
Fibrillation, when it is disturbing the patient, might be also an
indication to try catheter ablation, but when it is with a normal
heart rate, it is not.
Patients with hypoplastic left heart syndrome were excluded,
and they were not amenable for this type of Fontan operation. And
we could not see a difference at present between the patients with
TrA and the other patient group with regard to the success rate or
ablation rate. The patient numbers are too small, and the numbers
of failures are too small also. Atrial fibrillation alone is not an
indication to convert the Fontan tunnel to a total cavapulmonary
anastomosis.
Dr Marcus Haw (Southampton, United Kingdom). I come
from a center from which Dr Batts published his results with
ablation, and therefore we congratulate you with your fantastic
results for transcatheter intervention.
We followed very much Dr Mavroudis’ line in treating these
patients, and we have almost invariably found with the traditional
type of atriopulmonary connection that patients have a good deal
of effort intolerance, as well as the intermittent flutter, and I
wonder if you have any sort of outcome data in terms of your
patients’ functional status after a successful ablation?
Dr Weipert. The follow-up is short, and we do not have
functional data at present. Patients were satisfied with their clinical
condition when atrial flutter could be abolished or arrhythmia
frequency decreased. But we do not have objective methods where
we can say it is really an advantage for this patient.
Dr Haw. Thank you.
Dr Thomas L. Spray (Philadelphia, Pa). How many of these
patients in late follow-up ended up with a pacemaker, and how
many are still receiving antiarrhythmia medications?
Dr Weipert. Three patients ended up with a pacemaker, and 3
of them are taking amiodarone.
Dr Spray. And are they all receiving -blockers or only a
selected portion?
Dr Weipert. Most of the patients are receiving -blockers.
Dr Carlos Troconis (Caracas, Venezuela). Are those arrhyth-
mias surgically related, or were they related to dilatation of the
right atrium?
The reason for my question is because in the past 5 years, we
have operated on 3 patients older than 18 years with extracardiac
conduit, and all of them had normal sinus rhythm at follow-up. On
the other hand, we have 20 cases (2-4 years of age at operation)
over 10 years’ follow-up of extracardiac conduit, and we have not
seen any surgically related arrhythmias at all.
Dr Weipert. The lateral tunnel Fontan operation might be very
promising for the future.
There was a recent article from the Boston group: at 10 years,
90% of the patients with a lateral tunnel were free from new
supraventricular tachycardias. The lateral tunnel approach proba-
bly is the best solution for the univentricular heart at present.
In the patient with a failing Fontan operation, when there are
surgically amenable lesions, we go ahead and make a conversion,
but in these patients this was not the case.
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